Sclerostin-erbB-3 interactions: Modulation of erbB-3 activity by sclerostin

被引:10
作者
Craig, Theodore A. [1 ]
Kumar, Rajiv [1 ]
机构
[1] Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA
关键词
Sclerostin; Epidermal growth factor receptor; erbB-3; Osteoblast; Yeast two hybrid; EPIDERMAL-GROWTH-FACTOR; RECEPTOR-RELATED PROTEIN-5; STIMULATED BONE-FORMATION; SIGNALING PATHWAYS; INHIBITORY-ACTION; BMP ANTAGONIST; MUTATION; DENSITY; WNT; CHONDROGENESIS;
D O I
10.1016/j.bbrc.2010.10.048
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
To gain insights into the mechanism of action of sclerostin, a protein that regulates bone mass, we performed yeast two-hybrid analyses using human SOST (sclerostin) cDNA cloned into pGBKT7 DNA-binding domain vector as a bait, and a normalized, high-complexity, universal cDNA library in a GAL4 activating domain vector. We identified an interaction between sclerostin and the carboxyl-terminal portion of the receptor tyrosine-protein kinase erbB-3. To determine the biological relevance of this interaction, we treated MC3T3-E1 mouse osteoblast cells transfected with either a SOST expression plasmid or a control vector, with recombinant heregulin/neuregulin. Phospho-p44/42 (Thr202/Tyr204) MAPK was assessed in heregulin/neuregulin treated cells. We observed an increase in phospho-p44/42 (Thr202/Tyr204) MAPK concentrations in SOST transfected cells but not in cells transfected with a control vector, thus demonstrating a modulatory effect of sclerostin on heregulin/neuregulin signaling in osteoblasts. The data demonstrate that sclerostin functions in part, by modulating the activity of erbB-3. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:421 / 424
页数:4
相关论文
共 28 条
[1]
Ausubel F.M., 2007, CURRENT PROTOCOLS MO
[2]
CLINICAL FEATURES OF SCLEROSTEOSIS - REVIEW OF MANIFESTATIONS IN 25 AFFECTED INDIVIDUALS [J].
BEIGHTON, P ;
DURR, L ;
HAMERSMA, H .
ANNALS OF INTERNAL MEDICINE, 1976, 84 (04) :393-397
[3]
BEIGHTON P, 1977, CLIN GENET, V11, P1
[4]
REVIEW OF OSTEOPETROSES [J].
BEIGHTON, P ;
HORAN, F ;
HAMERSMA, H .
POSTGRADUATE MEDICAL JOURNAL, 1977, 53 (622) :507-516
[5]
BEIGHTON PH, 2010, SOST RELATED SCLEROS
[6]
High bone density due to a mutation in LDL-receptor-related protein 5 [J].
Boyden, LM ;
Mao, JH ;
Belsky, J ;
Mitzner, L ;
Farhi, A ;
Mitnick, MA ;
Wu, DQ ;
Insogna, K ;
Lifton, RP .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (20) :1513-1521
[7]
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein [J].
Brunkow, ME ;
Gardner, JC ;
Van Ness, J ;
Paeper, BW ;
Kovacevich, BR ;
Proll, S ;
Skonier, JE ;
Zhao, L ;
Sabo, PJ ;
Fu, YH ;
Alisch, RS ;
Gillett, L ;
Colbert, T ;
Tacconi, P ;
Galas, D ;
Hamersma, H ;
Beighton, P ;
Mulligan, JT .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (03) :577-589
[8]
CENTRELLA M, 1987, J BONE MINER RES, V2, P29
[9]
Expression of epidermal growth factor in transgenic mice causes growth retardation [J].
Chan, SY ;
Wong, RWC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (49) :38693-38698
[10]
COFFIN-COLLINS P A, 1989, International Journal of Developmental Biology, V33, P297